-
Je něco špatně v tomto záznamu ?
A unique case of AH-dominant type nodular pulmonary amyloidosis presenting as a spontaneous pneumothorax: a case report and review of the literature
V. Skopelidou, P. Hurník, L. Tulinský, V. Židlík, J. Lenz, P. Delongová, H. Hornychová, P. Flodr, T. Jelínek, L. Muroňová, D. Holub, P. Džubák, M. Hajdúch
Jazyk angličtina Země Švýcarsko
Typ dokumentu přehledy, kazuistiky
NLK
Directory of Open Access Journals
od 2021
PubMed Central
od 2021
Medline Complete (EBSCOhost)
od 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1995
- MeSH
- amyloidóza * komplikace diagnóza patologie MeSH
- lidé MeSH
- plíce diagnostické zobrazování patologie MeSH
- plicní nemoci * komplikace diagnóza patologie MeSH
- pneumotorax * diagnóza etiologie MeSH
- senioři nad 80 let MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- Publikační typ
- kazuistiky MeSH
- přehledy MeSH
Amyloidosis is a rare metabolic disorder primarily brought on by misfolding of an autologous protein, which causes its local or systemic deposition in an aberrant fibrillar form. It is quite rare for pulmonary tissue to be impacted by amyloidosis; of the three forms it can take when involving pulmonary tissue, nodular pulmonary amyloidosis is the most uncommon. Nodular pulmonary amyloidosis rarely induces clinical symptoms, and most often, it is discovered accidentally during an autopsy or via imaging techniques. Only one case of nodular pulmonary amyloidosis, which manifested as a spontaneous pneumothorax, was found in the literature. In terms of more precise subtyping, nodular amyloidosis is typically AL or mixed AL/AH type. No publications on AH-dominant type of nodular amyloidosis were found in the literature. We present a case of an 81 years-old male with nodular pulmonary AH-dominant type amyloidosis who presented with spontaneous pneumothorax. For a deeper understanding of the subject, this study also provides a review of the literature on cases with nodular pulmonary amyloidosis in relation to precise amyloid fibril subtyping. Since it is often a difficult process, accurate amyloid type identification is rarely accomplished. However, this information is very helpful for identifying the underlying disease process (if any) and outlining the subsequent diagnostic and treatment steps. Even so, it is crucial to be aware of this unit and make sure it is taken into consideration when making a differential diagnosis of pulmonary lesions.
Department of Clinical and Molecular Pathology University Hospital Olomouc Olomouc Czechia
Department of Hematooncology Faculty of Medicine University of Ostrava Ostrava Czechia
Department of Hematooncology University Hospital Ostrava Ostrava Czechia
Department of Pathology EUC Laboratoře CGB a s Ostrava Czechia
Department of Pathology Znojmo Hospital Znojmo Czechia
Department of Surgery University Hospital Ostrava Ostrava Czechia
Department of Surgical Studies Faculty of Medicine University of Ostrava Ostrava Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001232
- 003
- CZ-PrNML
- 005
- 20240213094446.0
- 007
- ta
- 008
- 240109e20230922sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/pore.2023.1611390 $2 doi
- 035 __
- $a (PubMed)37808084
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Skopelidou, Valeria $u Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czechia $u Institute of Molecular and Clinical Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, Ostrava, Czechia
- 245 12
- $a A unique case of AH-dominant type nodular pulmonary amyloidosis presenting as a spontaneous pneumothorax: a case report and review of the literature / $c V. Skopelidou, P. Hurník, L. Tulinský, V. Židlík, J. Lenz, P. Delongová, H. Hornychová, P. Flodr, T. Jelínek, L. Muroňová, D. Holub, P. Džubák, M. Hajdúch
- 520 9_
- $a Amyloidosis is a rare metabolic disorder primarily brought on by misfolding of an autologous protein, which causes its local or systemic deposition in an aberrant fibrillar form. It is quite rare for pulmonary tissue to be impacted by amyloidosis; of the three forms it can take when involving pulmonary tissue, nodular pulmonary amyloidosis is the most uncommon. Nodular pulmonary amyloidosis rarely induces clinical symptoms, and most often, it is discovered accidentally during an autopsy or via imaging techniques. Only one case of nodular pulmonary amyloidosis, which manifested as a spontaneous pneumothorax, was found in the literature. In terms of more precise subtyping, nodular amyloidosis is typically AL or mixed AL/AH type. No publications on AH-dominant type of nodular amyloidosis were found in the literature. We present a case of an 81 years-old male with nodular pulmonary AH-dominant type amyloidosis who presented with spontaneous pneumothorax. For a deeper understanding of the subject, this study also provides a review of the literature on cases with nodular pulmonary amyloidosis in relation to precise amyloid fibril subtyping. Since it is often a difficult process, accurate amyloid type identification is rarely accomplished. However, this information is very helpful for identifying the underlying disease process (if any) and outlining the subsequent diagnostic and treatment steps. Even so, it is crucial to be aware of this unit and make sure it is taken into consideration when making a differential diagnosis of pulmonary lesions.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 12
- $a pneumotorax $x diagnóza $x etiologie $7 D011030
- 650 12
- $a amyloidóza $x komplikace $x diagnóza $x patologie $7 D000686
- 650 _2
- $a plíce $x diagnostické zobrazování $x patologie $7 D008168
- 650 12
- $a plicní nemoci $x komplikace $x diagnóza $x patologie $7 D008171
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Hurník, Pavel $u Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czechia $u Institute of Molecular and Clinical Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, Ostrava, Czechia $u Department of Pathology, EUC Laboratoře CGB a.s., Ostrava, Czechia
- 700 1_
- $a Tulinský, Lubomír $u Department of Surgery, University Hospital Ostrava, Ostrava, Czechia $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czechia
- 700 1_
- $a Židlík, Vladimir $u Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czechia $u Institute of Molecular and Clinical Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, Ostrava, Czechia $u Department of Pathology, EUC Laboratoře CGB a.s., Ostrava, Czechia
- 700 1_
- $a Lenz, Jiří $u Department of Pathology, Znojmo Hospital, Znojmo, Czechia
- 700 1_
- $a Delongová, Patricie $u Institute of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czechia $u Institute of Molecular and Clinical Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, Ostrava, Czechia $u Department of Pathology, EUC Laboratoře CGB a.s., Ostrava, Czechia
- 700 1_
- $a Hornychová, Helena $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové, Hradec Králové, Czechia $u The Fingerland Department of Pathology, Charles University, University Hospital Hradec Králové, Hradec Králové, Czechia
- 700 1_
- $a Flodr, Patrik $u Department of Clinical and Molecular Pathology, University Hospital Olomouc, Olomouc, Czechia $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czechia
- 700 1_
- $a Jelínek, Tomáš $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czechia $u Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czechia
- 700 1_
- $a Muroňová, Ludmila $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czechia $u Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czechia
- 700 1_
- $a Holub, Dušan $u Institute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czechia
- 700 1_
- $a Džubák, Petr $u Institute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czechia
- 700 1_
- $a Hajdúch, Marián $u Institute for Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czechia
- 773 0_
- $w MED00180530 $t Pathology oncology research $x 1532-2807 $g Roč. 29 (20230922), s. 1611390
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37808084 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213094443 $b ABA008
- 999 __
- $a ok $b bmc $g 2049693 $s 1210926
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 29 $c - $d 1611390 $e 20230922 $i 1532-2807 $m Pathology oncology research $n Pathol Oncol Res $x MED00180530
- LZP __
- $a Pubmed-20240109